Live
AgilentHow Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics - Yahoo FinanceCellExpansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapyEndpoints NewsBiopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and moreScience Daily BiotechThe secret language behind animal cooperationEndpoints NewsEndpoints News History: 10 Years, Bootstrap to FTClinical OMICsImproving HSV-2 Vaccine Efficacy with Combination StrategyCellMultimodal imaging of gene expression, morphology, and activity of the same neuron10x Genomics News10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics - Zacks Investment ResearchFierceBiotechFDA warning slams Zoll Medical with multiple quality control and reporting violationsBioWorldHangzhou Innogate Pharma discovers new KAT inhibitorsBioWorldAlicorn synthesizes new AAK1 inhibitorsBioWorldChinese scientists identify new macrocyclic compounds as kinase inhibitors
Illumina Mar 23, 2026

Canaccord reiterates Hold on Illumina stock amid Roche competition - Investing.com

Canaccord reiterates Hold on Illumina stock amid Roche competition - Investing.com

Body unavailable. Use the original source.